BioLife Biopreservation Evidence Resources + New Citations

BioLife maintains an evidence page on our corporate website at biolifesolutions.com with links to presentations, journal articles, abstracts and posters citing the biopreservation efficacy of CryoStor and HypoThermosol.  These citation “evidence” pieces total over 345 strong and is constantly growing! Individual evidence citations (journal articles, abstracts, and posters citing our products) are searchable by title and…

Casdin Capital to Become Shareholder in BioLife Solutions – Investment Firm to Purchase Shares from Existing Holder

On April 9, 2018 BioLife Solutions Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media, (“BioLife” or the “Company”), announced that Casdin Capital LLC, (“Casdin”) a New York-based, life science-focused investment firm, has entered into an agreement to purchase 1,000,000 BioLife Solutions common shares in a private transaction from the Company’s second…

Pathologically expanded peripheral T helper cell subsets drives B cells in rheumatoid arthritis

Rao, Gurish, Marshall, Slowikowski, Fonseka, Liu, Donlin, Henderson, Wei, MizoGuchi, Teslovich, Weinblatt, Massarotti, Coblyn, Helfgott, Lee, Todd, Bykerk, Goodman, Pernis, Ivashkiv, Karlson, Nigrovic, Filer, Buckley, Lederer, Raychaudhuri, Brenner. Pathologically expanded peripheral T helper cell subsets drives B cells in rheumatoid arthritis. Nature 542, 110–114 (02 February 2017) doi:10.1038/nature20810